Quarterly Transactions Made in Silverback Therapeutics, Inc. (SBTX)
This table provides information about the institutional ownership of Silverback Therapeutics, Inc. (SBTX). The information is specifically focused on institutions that hold shares of Silverback Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,031,443 | 15,481 | 1,046,924 | — | 1,046,924 | |||
| Q4 2021 | 351,626 | 0 | 351,626 | 357,428 | 0 | 357,428 | -5,802 | |
| Q1 2022 | 28,213 | 0 | 28,213 | 488,370 | 0 | 488,370 | -460,157 | |
| Q2 2022 | 233,368 | 0 | 233,368 | 917,470 | 0 | 917,470 | -684,102 | |
| Q3 2022 | 50,366 | 0 | 50,366 | 23,634 | 0 | 23,634 | 26,732 | |
| Q4 2022 | 2,507,898 | 20,626,147 | 23,134,045 | 1,305,729 | 0 | 1,305,729 | 21,828,316 | |
| Q1 2023 | 3,476,643 | 2,284,435 | 5,761,078 | 1,441,474 | 0 | 1,441,474 | 4,319,604 | |
| Q2 2023 | 5,141,123 | 1,921,013 | 7,062,136 | 4,154,062 | 32,174 | 4,186,236 | 2,875,900 | |
| Q3 2023 | 11,595,377 | 8,649,460 | 20,244,837 | 7,137,750 | 0 | 7,137,750 | 13,107,087 | |
| Q4 2023 | 1,784,219 | 10,256,515 | 12,040,734 | 1,728,598 | 0 | 1,728,598 | 10,312,136 | |
| Q1 2024 | 4,725,984 | 1,842,079 | 6,568,063 | 3,605,571 | 0 | 3,605,571 | 2,962,492 | |
| Q2 2024 | 3,565,685 | 11,221,261 | 14,786,946 | 991,894 | 0 | 991,894 | 13,795,052 | |
| Q3 2024 | 3,931,581 | 4,486,068 | 8,417,649 | 5,124,048 | 0 | 5,124,048 | 3,293,601 | |